Bitcoin price today: rises to $116.5k on Trump 401k order, altcoins rally
Investing.com - Emerson (NYSE: EMR) reported third quarter EPS of $1.52, $0.01 better than the analyst estimate of $1.51. Revenue for the quarter came in at $4.55B versus the consensus estimate of $4.61B.
Guidance
Emerson sees Q4 2025 EPS of $1.58-$1.62 versus the analyst consensus of $1.61.
Emerson sees FY 2025 EPS of $6.00 versus the analyst consensus of $5.99.
Emerson’s stock price closed at $140.57. It is up 24.90% in the last 3 months and up 41.22% in the last 12 months.
Emerson saw 5 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See Emerson’s stock price’s past reactions to earnings here.
According to InvestingPro, Emerson’s Financial Health score is "fair performance".
Check out Emerson’s recent earnings performance, and Emerson’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar